ACTRN12623000133639尚未招募4 期
Continuous infusion of remimazolam for intraoperative sedation as a safe and effective option: a prospective clinical study.
Antonia Kustura, MD0 个研究点目标入组 50 人开始时间: 2023年2月8日最近更新:
适应症
试验速览
- 阶段
- 4 期
- 状态
- 尚未招募
- 发起方
- 入组人数
- 50
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Non-randomised trial
- 主要目的
- Treatment
- 盲法
- Open (masking not used)
入排标准
- 年龄范围
- 18 Years 至 80 Years（—）
- 性别
- All
入选标准
- •Adult patients between 18 and 80 years of age, ASA class I, II and III, scheduled for elective procedural sedation or sedation with regional anaesthesia.
排除标准
- •Exclusion criteria are age under 18 or over 80, allergy to any of the drugs used, body mass index (BMI) under 18 or over 30, patients with psychiatric diagnoses, and patient refusal.
研究者
相似试验
招募中
不适用
Anesthetic induction using remimazolam in patients undergoing cardiac surgeryDiseases of the circulatory systemKCT0006931Asan Medical Center60
已完成
不适用
Remimazolam during induction of anesthesia in patients with severe aortic stenosisSevere aortic stenosisJPRN-UMIN000042318agoya City University Graduate School of Medical Sciences, Department of Anesthesiology and Intensive Care Medicine20
招募中
Unknown
Efficacy and safety of general anestheticsScheduled non-cardiac surgeries under general anesthesiaJPRN-jRCTs061230049Miyoshi Hirotsugu69
已完成
不适用
Adequate infusion rate of remimazolam for induction of general anesthesia in adult patientsKCT0006805Samsung Medical Center44
尚未招募
不适用
Adequate infusion rate of remimazolam for induction of general anesthesia in elderly patients aged 65 or olderKCT0007902Samsung Medical Center50